Millennium Management’s Clearside Biomedical CLSD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-91,019
Closed -$116K 4127
2024
Q3
$116K Buy
91,019
+48,130
+112% +$61.1K ﹤0.01% 3824
2024
Q2
$55.8K Sell
42,889
-164,038
-79% -$213K ﹤0.01% 3772
2024
Q1
$317K Buy
206,927
+173,289
+515% +$265K ﹤0.01% 3482
2023
Q4
$39.4K Buy
+33,638
New +$39.4K ﹤0.01% 3832
2023
Q3
Sell
-33,298
Closed -$37.3K 4233
2023
Q2
$37.3K Buy
+33,298
New +$37.3K ﹤0.01% 3998
2023
Q1
Sell
-53,814
Closed -$60K 4592
2022
Q4
$60K Sell
53,814
-105,648
-66% -$118K ﹤0.01% 4415
2022
Q3
$180K Sell
159,462
-146,258
-48% -$165K ﹤0.01% 4485
2022
Q2
$449K Sell
305,720
-755,195
-71% -$1.11M ﹤0.01% 3968
2022
Q1
$2.43M Buy
1,060,915
+690,417
+186% +$1.58M ﹤0.01% 2902
2021
Q4
$1.02M Buy
370,498
+105,026
+40% +$289K ﹤0.01% 3471
2021
Q3
$1.59M Buy
265,472
+90,437
+52% +$543K ﹤0.01% 3232
2021
Q2
$852K Sell
175,035
-11,346
-6% -$55.2K ﹤0.01% 3821
2021
Q1
$460K Buy
186,381
+118,327
+174% +$292K ﹤0.01% 3707
2020
Q4
$186K Buy
+68,054
New +$186K ﹤0.01% 3743
2020
Q3
Sell
-144,628
Closed -$272K 3639
2020
Q2
$272K Buy
144,628
+73,442
+103% +$138K ﹤0.01% 3004
2020
Q1
$121K Sell
71,186
-179,873
-72% -$306K ﹤0.01% 2840
2019
Q4
$728K Sell
251,059
-29,474
-11% -$85.5K ﹤0.01% 2555
2019
Q3
$176K Sell
280,533
-214,283
-43% -$134K ﹤0.01% 3173
2019
Q2
$481K Buy
+494,816
New +$481K ﹤0.01% 2770
2019
Q1
Sell
-547,873
Closed -$586K 3457
2018
Q4
$586K Sell
547,873
-351,555
-39% -$376K ﹤0.01% 2516
2018
Q3
$5.53M Sell
899,428
-346,616
-28% -$2.13M 0.01% 1521
2018
Q2
$13.3M Sell
1,246,044
-151,688
-11% -$1.62M 0.02% 1031
2018
Q1
$15M Buy
1,397,732
+1,372,303
+5,397% +$14.7M 0.02% 1013
2017
Q4
$178K Buy
+25,429
New +$178K ﹤0.01% 3326
2017
Q2
Sell
-20,480
Closed -$163K 3247
2017
Q1
$163K Sell
20,480
-271,236
-93% -$2.16M ﹤0.01% 3025
2016
Q4
$2.61M Buy
+291,716
New +$2.61M 0.01% 1594
2016
Q3
Sell
-69,152
Closed -$485K 3035
2016
Q2
$485K Buy
+69,152
New +$485K ﹤0.01% 2280